BRIEF published on 04/30/2024 at 11:05, 1 year 7 months ago New Partnership Between BioMed X Institute and Merck Focuses on Immuno-Oncology Cancer Research BioMed X Institute Immunotherapy Merck Tumor Immunogenicity
PRESS RELEASE published on 04/30/2024 at 11:00, 1 year 7 months ago New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg Biomedical research institute, BioMed X, partners with Merck to develop novel immunotherapeutic strategies to enhance tumor immunogenicity for cancer patients Cancer Research Immunotherapy Merck Tumor Immunogenicity BioMed X
PRESS RELEASE published on 02/06/2024 at 16:00, 1 year 10 months ago New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine BioMed X Institute and Universitatsmedizin Mannheim researchers publish results of collaboration on new neoepitope vaccine in diffuse midline glioma in Science Advances BioMed X Institute Universitatsmedizin Mannheim Neoepitope Vaccine Diffuse Midline Glioma Science Advances
PRESS RELEASE published on 11/07/2023 at 12:00, 2 years 1 month ago BioMed X Launches a New Call for Application in Autoimmune Disease Research
PRESS RELEASE published on 10/31/2023 at 17:00, 2 years 1 month ago BioMed X and AbbVie Start New Research Project in the USA
PRESS RELEASE published on 06/29/2023 at 11:00, 2 years 5 months ago BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
PRESS RELEASE published on 04/27/2023 at 14:00, 2 years 7 months ago BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus
PRESS RELEASE published on 04/04/2023 at 11:00, 2 years 8 months ago BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Published on 12/20/2025 at 00:30, 1 day 4 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 1 day 6 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 1 day 10 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 1 day 14 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 1 day 15 hours ago Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF
Published on 12/20/2025 at 16:45, 12 hours 2 minutes ago Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 18 hours 42 minutes ago FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 1 day 6 hours ago EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 1 day 7 hours ago IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 1 day 8 hours ago Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy
Published on 12/19/2025 at 21:57, 1 day 6 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 1 day 20 hours ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 1 day 20 hours ago Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 1 day 21 hours ago EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 1 day 21 hours ago EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION
